Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...
Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...
With the Canadian economy experiencing a contraction in November and a recent interest rate cut by the Bank of Canada due to tariff uncertainties, investors are navigating a complex landscape. In such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results